Composition and applications of focus libraries to phenotypic assays

Frontiers in Pharmacology

Volumn 5 JUN, Issue , 2014, Pages

  Wassermann, Anne Mai ^a   Camargo, Luiz Miguel ^a   Auld, Douglas S ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Chemical libraries; Chemical probes; Focused library; High throughput screening; Phenotypic assays

Indexed keywords

BAMBUTEROL; CYCLOHEXIMIDE; DACTINOMYCIN; DOXYCYCLINE; ETACRYNIC ACID; FLUDARABINE PHOSPHATE; FORSKOLIN; MODAFINIL; SILDENAFIL; TERBUTALINE;

BIOASSAY; BIODIVERSITY; BIOLOGICAL ACTIVITY; CHEMICAL ANALYSIS; CHEMICAL DATABASE; CHEMICAL STRUCTURE; DATA ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR LIBRARY; MOLECULAR PROBE; NONHUMAN; PHENOTYPE; POLYPHARMACOLOGY; PROTEIN TARGETING; REVIEW;

EID: 84904731398     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00164     Document Type: Review

References (96)

1. Amberger, J., Bocchini, C., and Hamosh, A. (2011). A new face and new challenges for Online Mendelian Inheritance in Man (OMIM(R)). Hum Mutat 32, 564-567. 10.1002/humu.21466
2. Anastasiou, D., Poulogiannis, G., Asara, J.M., Boxer, M.B., Jiang, J.K., Shen, M., et al. (2011). Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278-1283. 10.1126/science.1211485
3. Auld, D.S., and Acker, M.G. (2014). Considerations for the design and reporting of enzyme assays in high-throughput screening applications. Perspectives in Science 1, 56-73. http://dx.doi.org/10.1016/j.pisc.2013.12.001
4. Baell, J.B., and Holloway, G.A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53, 2719-2740. 10.1021/jm901137j
5. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C.J., Mclauchlan, H., et al. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem J 408, 297-315. 10.1042/BJ20070797
6. Basu, S., Ellinger, B., Rizzo, S., Deraeve, C., Schurmann, M., Preut, H., et al. (2011). Biology561 oriented synthesis of a natural-product inspired oxepane collection yields a small562 molecule activator of the Wnt-pathway. Proc Natl Acad Sci U S A 108, 6805-6810. 10.1073/pnas.1015269108
7. Besnard, J., Ruda, G.F., Setola, V., Abecassis, K., Rodriguiz, R.M., Huang, X.P., et al. (2012). Automated design of ligands to polypharmacological profiles. Nature 492, 215-220. 10.1038/nature11691
8. Blake, J.A., Dolan, M., Drabkin, H., Hill, D.P., Li, N., Sitnikov, D., et al. (2013). Gene Ontology annotations and resources. Nucleic Acids Res 41, D530-535. 10.1093/nar/gks1050
9. Bliss, T., Collingridge, G., and Morris, R. (2004). Long-term potentiation: enhancing neuroscience for 30 years. Oxford University Press.
10. Bloch, K., and Rittenberg, D. (1942). On the Utilization of Acetic Acid for Cholesterol Formation. J. Biol. Chem. 145, 625-636.
11. Brimacombe, K.R., Anastasiou, D., Hong, B.S., Tempel, W., Dimov, S., Veith, H., et al. (2010). "ML285 affects reactive oxygen species' inhibition of pyruvate kinase M2," in Probe Reports from the NIH Molecular Libraries Program. (Bethesda (MD).
12. Chen, M., Zhang, M., Borlak, J., and Tong, W. (2012). A decade of toxicogenomic research and its contribution to toxicological science. Toxicol Sci 130, 217-228. 10.1093/toxsci/kfs223
13. De Souza, A., Bittker, J.A., Lahr, D.L., Brudz, S., Chatwin, S., Oprea, T.I., et al. (2014). An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines. J Biomol Screen 19, 614-627. 10.1177/1087057113517139
14. Dobbelstein, M., and Moll, U. (2014). Targeting tumour-supportive cellular machineries in anticancer drug development. Nat Rev Drug Discov 13, 179-196. 10.1038/nrd4201
15. Dolle, R.E., Le Bourdonnec, B., Morales, G.A., Moriarty, K.J., and Salvino, J.M. (2006). Comprehensive survey of combinatorial library synthesis: 2005. J Comb Chem 8, 597-635. 10.1021/cc060095m
16. Dranchak, P., Macarthur, R., Guha, R., Zuercher, W.J., Drewry, D.H., Auld, D.S., et al. (2013). Profile of the GSK published protein kinase inhibitor set across ATP-dependent and independent luciferases: implications for reporter-589 gene assays. PLoS One 8, e57888. 10.1371/journal.pone.0057888
17. Evans, B.E., Rittle, K.E., Bock, M.G., Dipardo, R.M., Freidinger, R.M., Whitter, W.L., et al. (1988). Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem 31, 2235-2246.
18. Feng, B.Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B.K., et al. (2007). A high-throughput screen for aggregation-based inhibition in a large compound library. J Med Chem 50, 2385-2390. 10.1021/jm061317y
19. Flicek, P., Amode, M.R., Barrell, D., Beal, K., Brent, S., Chen, Y., et al. (2011). Ensembl 2011. Nucleic Acids Res 39, D800-806. 10.1093/nar/gkq1064
20. Frye, S.V. (2010). The art of the chemical probe. Nat Chem Biol 6, 159-161. nchembio.296 [pii] 10.1038/nchembio.296
21. Ganter, B., Tugendreich, S., Pearson, C.I., Ayanoglu, E., Baumhueter, S., Bostian, K.A., et al. (2005). Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 119, 219-244. 10.1016/j.jbiotec.2005.03.022
22. Garcia-Serna, R., and Mestres, J. (2011). Chemical probes for biological systems. Drug Discov Today 16, 99-106. 10.1016/j.drudis.2010.11.004
23. Gaulton, A., Bellis, L.J., Bento, A.P., Chambers, J., Davies, M., Hersey, A., et al. (2012). ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40, D1100-1107. 10.1093/nar/gkr777
24. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89, 5547-5551.
25. Gujral, T.S., Peshkin, L., and Kirschner, M.W. (2014). Exploiting polypharmacology for drug target deconvolution. Proc Natl Acad Sci U S A 111, 5048-5053.
26. Guo, T., and Hobbs, D.W. (2003). Privileged structure-based combinatorial libraries targeting G protein-coupled receptors. Assay Drug Dev Technol 1, 579-592.
27. Hager T. (2006). The Demon Under the Microscope: From Battlefield Hospitals to Nazi Labs, One Doctor's Heroic Search for the World's First Miracle Drug. New York: Three Rivers Press;: Miracle Drug Random House, Inc.
28. Harris, C.J., Hill, R.D., Sheppard, D.W., Slater, M.J., and Stouten, P.F. (2011). The design and application of target-focused compound libraries. Comb Chem High Throughput Screen 14, 521-531.
29. Heller, S., Mcnaught, A., Stein, S., Tchekhovskoi, D., and Pletnev, I. (2013). InChI-the worldwide chemical structure identifier standard. J Cheminform 5, 7. 10.1186/1758-2946-5-7
30. Hert, J., Irwin, J.J., Laggner, C., Keiser, M.J., and Shoichet, B.K. (2009). Quantifying biogenic bias in screening libraries. Nat Chem Biol 5, 479-483. 10.1038/nchembio.180
31. Ho, P.I., Yue, K., Pandey, P., Breault, L., Harbinski, F., Mcbride, A.J., et al. (2013). Reporter enzyme inhibitor study to aid assemblyl of orthogonal reporter gene assays. ACS Chem Biol 8, 1009-1017. 10.1021/cb3007264
32. Hopkins, A.L. (2008). Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4, 682-690. 10.1038/nchembio.118
33. Houghten, R.A., Dooley, C.T., and Appel, J.R. (2006). In vitro and direct in vivo testing of mixture-based combinatorial libraries for the identification of highly active and specific opiate ligands. AAPS J 8, E371-382. 10.1208/aapsj080242
34. Houghten, R.A., Pinilla, C., Giulianotti, M.A., Appel, 635 J.R., Dooley, C.T., Nefzi, A., et al. (2008). Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. J Comb Chem 10, 3-19. 10.1021/cc7001205
35. Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., et al. (2011). The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci Transl Med 3, 80ps16. 10.1126/scitranslmed.3001862
36. Huttunen, K.M., Raunio, H., and Rautio, J. (2011). Prodrugs--from serendipity to rational design. Pharmacol Rev 63, 750-771. 10.1124/pr.110.003459
37. Inglese, J., and Auld, D. (2009). "High Throughput Screening (HTS) Techniques: Applications in Chemical Biology. In," in Wiley Encyclopedia of Chemical Biology Vol. 2, ed. T.P. Begley. (Hoboken: John Wiley & Sons), 260-274.
38. Inglese, J., Auld, D.S., Jadhav, A., Johnson, R.L., Simeonov, A., Yasgar, A., et al. (2006). Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci U S A 103, 11473-11478. 10.1073/pnas.0604348103
39. Inglese, J., Johnson, R.L., Simeonov, A., Xia, M., Zheng, W., Austin, C.P., et al. (2007). High653 throughput screening assays for the identification of chemical probes. Nat Chem Biol 3, 466-479. 10.1038/nchembio.2007.17
40. Jaeger, S., Min, J., Nigsch, F., Camargo, M., Hutz, J., Cornett, A., et al. (2014). Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer. J Biomol Screen 19, 791-802. 10.1177/1087057114522690
41. Johnston, P.A., Soares, K.M., Shinde, S.N., Foster, C.A., Shun, T.Y., Takyi, H.K., et al. (2008). Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents. Assay Drug Dev Technol 6, 505-518. 10.1089/adt.2008.151
42. Kalliokoski, T., Kramer, C., Vulpetti, A., and Gedeck, P. (2013). Comparability of mixed IC50 data-a statistical analysis. PLoS One 8, e61007. 10.1371/journal.pone.0061007
43. Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., and Tanabe, M. (2014). Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 42, D199-205. 10.1093/nar/gkt1076
44. Kavlock, R., Chandler, K., Houck, K., Hunter, S., Judson, R., Kleinstreuer, N., et al. (2012). Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. Chem Res Toxicol 25, 1287-1302. 10.1021/tx3000939
45. Klekota, J., and Roth, F.P. (2008). Chemical substructures that enrich for biological activity. Bioinformatics 24, 2518-2525. 10.1093/bioinformatics/btn479
46. Knudsen, T., Martin, M., Chandler, K., Kleinstreuer, N., Judson, R., and Sipes, N. (2013). Predictive models and computational toxicology. Methods Mol Biol 947, 343-374. 10.1007/978-1-62703-131-8_26
47. Kramer, C., Kalliokoski, T., Gedeck, P., and Vulpetti, A. (2012). The experimental uncertainty of heterogeneous public K(i) data. J Med Chem 55, 5165-5173. 10.1021/jm300131x
48. Kramer, C., and Lewis, R. (2012). QSARs, data and error in the modern age of drug discovery. Curr Top Med Chem 12, 1896-1902.
49. Krier, M., Bret, G., and Rognan, D. (2006). Assessing the scaffold diversity of screening libraries. J Chem Inf Model 46, 512-524. 10.1021/ci050352v research. Nat Rev Cancer 7, 54-60. 10.1038/nrc2044
50. Laurenza, A., Khandelwal, Y., De Souza, N.J., Rupp, R.H., Metzger, H., and Seamon, K.B. (1987). Stimulation of adenylate cyclase by water-soluble analogues of forskolin. Mol Pharmacol 32, 133-139.
51. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A.C., Liu, Y., et al. (2014). DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42, D1091-1097. 10.1093/nar/gkt1068
52. Levine, D.M., Haynor, D.R., Castle, J.C., Stepaniants, S.B., Pellegrini, M., Mao, M., et al. (2006). Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways. Genome Biol 7, R93. 10.1186/gb-2006-7-10-r93
53. Lipinski, C.A., Lonbardo, F., Dominy, B.W., and Feeney, P.J. (1997). Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discover and Development Settings. Adv. Drug Delivery Rev. 23, 3-25.
54. Liu, Y., Platchek, M., Kement, B., Bee, W.T., Truong, M., Zeng, X., et al. (2014). A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway697 selective regulators of histone 3 K27 tri-methylation. Mol Biosyst 10, 251-257. 10.1039/c3mb70413k
55. Lopez-Vallejo, F., Giulianotti, M.A., Houghten, R.A., and Medina-Franco, J.L. (2012). Expanding the medicinally relevant chemical space with compound libraries. Drug Discov Today 17, 718-726. 10.1016/j.drudis.2012.04.001
56. Lounkine, E., Keiser, M.J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J.L., et al. (2012). Large-scale prediction and testing of drug activity on side-effect targets. Nature 486, 361-367. 10.1038/nature11159
57. Lowrie, J.F., Delisle, R.K., Hobbs, D.W., and Diller, D.J. (2004). The different strategies for designing GPCR and kinase targeted libraries. Comb Chem High Throughput Screen 7, 495-510.
58. Maglott, D., Ostell, J., Pruitt, K.D., and Tatusova, T. (2011). Entrez Gene: gene-centered information at NCBI. Nucleic Acids Research 39, D52-D57. Doi 10.1093/Nar/Gkq1237
59. Mason, J.S., Good, A.C., and Martin, E.J. (2001). 3-D pharmacophores in drug discovery. Curr Pharm Des 7, 567-597.
60. Matter, H. (1997). Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. J Med Chem 40, 1219-1229. 10.1021/jm960352+
61. Medina-Franco, J.L., Giulianotti, M.A., Welmaker, G.S., and Houghten, R.A. (2013). Shifting from the single to the multitarget paradigm in drug discovery. Drug Discov Today 18, 495-501. 10.1016/j.drudis.2013.01.008
62. Monga, M., and Sausville, E.A. (2002). Developmental therapeutics program at the NCI: molecular target and drug discovery process. Leukemia 16, 520-526. 10.1038/sj.leu.2402464
63. Munos, B. (2009). Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov 8, 959-968. 10.1038/nrd2961
64. Munos, B. (2013). A forensic analysis of drug targets from 2000 through 2012. Clin Pharmacol Ther 94, 407-411. 10.1038/clpt.2013.126
65. Nielsen, T.E., and Schreiber, S.L. (2008). Towards the optimal screening collection: a synthesis strategy. Angew Chem Int Ed Engl 47, 48-56. 10.1002/anie.200703073
66. Zhang, E., Kuffa, P., et al. (2004). Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat Struct Mol Biol 11, 1192-1197. 10.1038/nsmb859
67. Orry, A.J., Abagyan, R.A., and Cavasotto, C.N. (2006). Structure-based development of target731 specific compound libraries. Drug Discov Today 11, 261-266. 10.1016/S1359-6446(05)03717-7
68. Owen, S.C., Doak, A.K., Ganesh, A.N., Nedyalkova, L., Mclaughlin, C.K., Shoichet, B.K., et al. (2014). Colloidal Drug Formulations Can Explain "Bell-Shaped" Concentration-Response Curves. ACS Chem Biol. 10.1021/cb4007584
69. Petrone, P.M., Simms, B., Nigsch, F., Lounkine, E., Kutchukian, P., Cornett, A., et al. (2012). Rethinking molecular similarity: comparing compounds on the basis of biological activity. ACS Chem Biol 7, 1399-1409. 10.1021/cb3001028
70. Petrone, P.M., Wassermann, A.M., Lounkine, E., Kutchukian, P., Simms, B., Jenkins, J., et al. (2013). Biodiversity of small molecules--a new perspective in screening set selection. Drug Discov Today 18, 674-680. 10.1016/j.drudis.2013.02.005
71. Reddy, A.S., and Zhang, S. (2013). Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol 6, 41-47. 10.1586/ecp.12.74
72. Renner, S., Popov, M., Schuffenhauer, A., Roth, H.J., Breitenstein, W., Marzinzik, A., et al. (2011). Recent trends and observations in the design of high-quality screening collections. Future Med Chem 3, 751-766. 10.4155/fmc.11.15
73. Root, D.E., Flaherty, S.P., Kelley, B.P., and Stockwell, B.R. (2003). Biological mechanism profiling using an annotated compound library. Chem Biol 10, 881-892.
74. Roth, B.L., Sheffler, D.J., and Kroeze, W.K. (2004). Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3, 353-359. 10.1038/nrd1346
75. Sanchez-Martin, R.M., Mittoo, S., and Bradley, M. (2004). The impact of combinatorial methodologies on medicinal chemistry. Curr Top Med Chem 4, 653-669.
76. Schulz, M.M., Reisen, F., Zgraggen, S., Fischer, S., Yuen, D., Kang, G.J., et al. (2012). Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis. Proc Natl Acad Sci U S A 109, E2665-2674. 10.1073/pnas.1206036109
77. Simeonov, A., Jadhav, A., Thomas, C.J., Wang, Y., Huang, R., Southall, N.T., et al. (2008). Fluorescence spectroscopic profiling of compound libraries. J Med Chem 51, 2363-2371. 10.1021/jm701301m
78. Sternbach, L.H. (1979). The benzodiazepine story. J Med Chem 22, 1-7.
79. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545-15550. 10.1073/pnas.0506580102
80. Swinney, D.C., and Anthony, J. (2011). How were new medicines discovered? Nat Rev Drug Discov 10, 507-519. 10.1038/nrd3480
81. Taunton, J., Collins, J.L., and Schreiber, S.L. (1996a). Synthesis of natural and modified trapoxins, useful reagents for exploring histone deacetylase function. J. Am. Chem. Soc. 118, 10412-10422.
82. Taunton, J., Hassig, C.A., and Schreiber, S.L. (1996b). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411
83. Thomas, C.A., Jr., Springer, P.A., Loeb, G.E., Berwald-Netter, Y., and Okun, L.M. (1972). A miniature microelectrode array to monitor the bioelectric activity of cultured cells. Exp Cell Res 74, 61-66.
84. Thorne, N., Auld, D.S., and Inglese, J. (2010). Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol 14, 315-324. 10.1016/j.cbpa.2010.03.020
85. Thorne, N., Shen, M., Lea, W.A., Simeonov, A., Lovell, S., Auld, D.S., et al. (2012). Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter. Chem Biol 19, 1060-1072. 10.1016/j.chembiol.2012.07.015
86. Tipton, K.F., Armstrong, R.N., B.M., B., A., B., A., C.-B., P.J., H., et al. (2014). Standards for Reporting Enzyme Data: The STRENDA Consortium: What it aims to do and why it should be helpful. Perspectives in Science 1, 131-137.
87. Uehara, T., Ono, A., Maruyama, T., Kato, I., Yamada, H., Ohno, Y., et al. (2010). The Japanese toxicogenomics project: application of toxicogenomics. Mol Nutr Food Res 54, 218-227. 10.1002/mnfr.200900169
88. Uniprot, C. (2010). The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 38, D142-148. 10.1093/nar/gkp846
89. Vedadi, M., Barsyte-Lovejoy, D., Liu, F., Rival-Gervier, S., Allali-Hassani, A., Labrie, V., et al. (2011). A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol 7, 566-574. 10.1038/nchembio.599
90. Wallace, I.M., Urbanus, M.L., Luciani, G.M., Burns, A.R., Han, M.K., Wang, H., et al. (2011). Compound prioritization methods increase rates of chemical probe discovery in model organisms. Chem Biol 18, 1273-1283. 10.1016/j.chembiol.2011.07.018
91. Wang, Y., Suzek, T., Zhang, J., Wang, J., He, S., Cheng, T., et al. (2014). PubChem BioAssay: 2014 update. Nucleic Acids Res 42, D1075-1082. 10.1093/nar/gkt978
92. Weill, N., and Rognan, D. (2009). Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands. J Chem Inf Model 49, 1049-1062. 10.1021/ci800447g
93. Weininger, D. (1988). Smiles, a Chemical Language and Information-System.1. Introduction to Methodology and Encoding Rules. Journal of Chemical Information and Computer Sciences 28, 31-36. Doi 10.1021/Ci00057a005
94. Workman, P., and Collins, I. (2010). Probing the probes: fitness factors for small molecule tools. Chem Biol 17, 561-577. S1074-5521(10)00198-5 [pii] 10.1016/j.chembiol.2010.05.013
95. Zhang, J.H., Kang, Z.B., Ardayfio, O., Ho, P.I., Smith, T., Wallace, I., et al. (2013). Application of Titration-Based Screening for the Rapid Pilot Testing of High-Throughput Assays. J Biomol Screen. 10.1177/1087057113512151
96. Zimmermann, T.J., Roy, S., Martinez, N.E., Ziegler, S., Hedberg, C., and Waldmann, H. (2013). Biology-oriented synthesis of a tetrahydroisoquinoline-based compound collection targeting microtubule polymerization. Chembiochem 14, 295-300. 10.1002/cbic.201200711